These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18799289)

  • 41. Association of NPAS3 exonic variation with schizophrenia.
    Macintyre G; Alford T; Xiong L; Rouleau GA; Tibbo PG; Cox DW
    Schizophr Res; 2010 Jul; 120(1-3):143-9. PubMed ID: 20466522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired intellect and memory: a missing link between genetic risk and schizophrenia?
    Toulopoulou T; Goldberg TE; Mesa IR; Picchioni M; Rijsdijk F; Stahl D; Cherny SS; Sham P; Faraone SV; Tsuang M; Weinberger DR; Seidman LJ; Murray RM
    Arch Gen Psychiatry; 2010 Sep; 67(9):905-13. PubMed ID: 20819984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The AKT1 gene is associated with attention and brain morphology in schizophrenia.
    Ohi K; Hashimoto R; Yasuda Y; Fukumoto M; Nemoto K; Ohnishi T; Yamamori H; Takahashi H; Iike N; Kamino K; Yoshida T; Azechi M; Ikezawa K; Tanimukai H; Tagami S; Morihara T; Okochi M; Tanaka T; Kudo T; Iwase M; Kazui H; Takeda M
    World J Biol Psychiatry; 2013 Mar; 14(2):100-13. PubMed ID: 22150081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia.
    Donohoe G; Rose E; Frodl T; Morris D; Spoletini I; Adriano F; Bernardini S; Caltagirone C; Bossù P; Gill M; Corvin AP; Spalletta G
    Neuroimage; 2011 Feb; 54(3):2132-7. PubMed ID: 20934520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia.
    Mansour HA; Wood J; Logue T; Chowdari KV; Dayal M; Kupfer DJ; Monk TH; Devlin B; Nimgaonkar VL
    Genes Brain Behav; 2006 Mar; 5(2):150-7. PubMed ID: 16507006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DISC1 (disrupted-in-schizophrenia 1) is associated with cortical grey matter volumes in the human brain: a voxel-based morphometry (VBM) study.
    Trost S; Platz B; Usher J; Scherk H; Wobrock T; Ekawardhani S; Meyer J; Reith W; Falkai P; Gruber O
    J Psychiatr Res; 2013 Feb; 47(2):188-96. PubMed ID: 23140672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia.
    Matsumoto M; Straub RE; Marenco S; Nicodemus KK; Matsumoto S; Fujikawa A; Miyoshi S; Shobo M; Takahashi S; Yarimizu J; Yuri M; Hiramoto M; Morita S; Yokota H; Sasayama T; Terai K; Yoshino M; Miyake A; Callicott JH; Egan MF; Meyer-Lindenberg A; Kempf L; Honea R; Vakkalanka RK; Takasaki J; Kamohara M; Soga T; Hiyama H; Ishii H; Matsuo A; Nishimura S; Matsuoka N; Kobori M; Matsushime H; Katoh M; Furuichi K; Weinberger DR
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6133-8. PubMed ID: 18413613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.
    Green MJ; Cairns MJ; Wu J; Dragovic M; Jablensky A; Tooney PA; Scott RJ; Carr VJ;
    Mol Psychiatry; 2013 Jul; 18(7):774-80. PubMed ID: 22733126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1.
    Salsano E; Croci L; Maderna E; Lupo L; Pollo B; Giordana MT; Consalez GG; Finocchiaro G
    Neuro Oncol; 2007 Jul; 9(3):298-307. PubMed ID: 17522332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression.
    Laywer G; Nyman H; Agartz I; Arnborg S; Jönsson EG; Sedvall GC; Hall H
    BMC Psychiatry; 2006 Aug; 6():31. PubMed ID: 16901336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophrenia.
    Brent BK; Rosso IM; Thermenos HW; Holt DJ; Faraone SV; Makris N; Tsuang MT; Seidman LJ
    Schizophr Res; 2016 Jan; 170(1):123-9. PubMed ID: 26621001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia.
    Voineskos AN; Felsky D; Kovacevic N; Tiwari AK; Zai C; Chakravarty MM; Lobaugh NJ; Shenton ME; Rajji TK; Miranda D; Pollock BG; Mulsant BH; McIntosh AR; Kennedy JL
    Cereb Cortex; 2013 Sep; 23(9):2044-57. PubMed ID: 22772651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.
    Quednow BB; Brzózka MM; Rossner MJ
    Cell Mol Life Sci; 2014 Aug; 71(15):2815-35. PubMed ID: 24413739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia.
    Poletti S; Radaelli D; Bosia M; Buonocore M; Pirovano A; Lorenzi C; Cavallaro R; Smeraldi E; Benedetti F
    Eur Psychiatry; 2014 May; 29(4):219-25. PubMed ID: 24076156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability.
    Burdick KE; DeRosse P; Kane JM; Lencz T; Malhotra AK
    Am J Psychiatry; 2010 Apr; 167(4):436-43. PubMed ID: 20080979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adding evidence to the role of NEUROG1 in congenital cranial dysinnervation disorders.
    Dupont J; Vieira JP; Tavares ALT; Conceição CR; Khan S; Bertoli-Avella AM; Sousa AB
    Clin Genet; 2021 Apr; 99(4):588-593. PubMed ID: 33439489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.
    Stewart SE; Platko J; Fagerness J; Birns J; Jenike E; Smoller JW; Perlis R; Leboyer M; Delorme R; Chabane N; Rauch SL; Jenike MA; Pauls DL
    Arch Gen Psychiatry; 2007 Feb; 64(2):209-14. PubMed ID: 17283288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An exploratory association study of the influence of dysbindin and neuregulin polymorphisms on brain morphometry in patients with schizophrenia and healthy subjects from South India.
    Thirunavukkarasu P; Vijayakumari AA; John JP; Halahalli HN; Paul P; Sen S; Purushottam M; Jain S
    Asian J Psychiatr; 2014 Aug; 10():62-8. PubMed ID: 25042954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.